Biologics and the Cutaneous Fibrosis Treatment Market: Targeting...

added blog Health

2026-10-27 12:47:07 - Translate -

Biologics and the Cutaneous Fibrosis Treatment Market: Targeting the Fibrotic Pathway

Fibrosis is driven by complex biological pathways — TGF-beta signalling, connective tissue growth factor (CTGF), and immune dysregulation among them. Biologics that target these pathways offer the potential to slow or reverse fibrosis, and they are reshaping the cutaneous fibrosis treatment market. Biologic therapies — including monoclonal antibodies and fusion proteins — aim...

0 Comments 0 Shares 183 Views 0 Reviews